Report Detail

Pharma & Healthcare Global Testosterone Replacement Therapy Market Growth 2019-2024

  • RnM2895207
  • |
  • 07 February, 2019
  • |
  • Global
  • |
  • 159 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.

Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.

North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.

North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.

Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)
Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Testosterone Replacement Therapy market will register a -4.2% CAGR in terms of revenue, the global market size will reach US$ 1410 million by 2024, from US$ 1820 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Testosterone Replacement Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Replacement Therapy market by product type, application, key manufacturers and key regions and countries.

This study considers the Testosterone Replacement Therapy value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Gels
Injections
Patches
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Testosterone Replacement Therapy consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Testosterone Replacement Therapy market by identifying its various subsegments.
Focuses on the key global Testosterone Replacement Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Testosterone Replacement Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Testosterone Replacement Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Testosterone Replacement Therapy Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Testosterone Replacement Therapy Consumption 2014-2024
        • 2.1.2 Testosterone Replacement Therapy Consumption CAGR by Region
      • 2.2 Testosterone Replacement Therapy Segment by Type
        • 2.2.1 Gels
        • 2.2.2 Injections
        • 2.2.3 Patches
        • 2.2.4 Other
      • 2.3 Testosterone Replacement Therapy Consumption by Type
        • 2.3.1 Global Testosterone Replacement Therapy Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Testosterone Replacement Therapy Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Testosterone Replacement Therapy Sale Price by Type (2014-2019)
      • 2.4 Testosterone Replacement Therapy Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
        • 2.4.3 Others
      • 2.5 Testosterone Replacement Therapy Consumption by Application
        • 2.5.1 Global Testosterone Replacement Therapy Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Testosterone Replacement Therapy Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Testosterone Replacement Therapy Sale Price by Application (2014-2019)

      3 Global Testosterone Replacement Therapy by Players

      • 3.1 Global Testosterone Replacement Therapy Sales Market Share by Players
        • 3.1.1 Global Testosterone Replacement Therapy Sales by Players (2017-2019)
        • 3.1.2 Global Testosterone Replacement Therapy Sales Market Share by Players (2017-2019)
      • 3.2 Global Testosterone Replacement Therapy Revenue Market Share by Players
        • 3.2.1 Global Testosterone Replacement Therapy Revenue by Players (2017-2019)
        • 3.2.2 Global Testosterone Replacement Therapy Revenue Market Share by Players (2017-2019)
      • 3.3 Global Testosterone Replacement Therapy Sale Price by Players
      • 3.4 Global Testosterone Replacement Therapy Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Testosterone Replacement Therapy Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Testosterone Replacement Therapy Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Testosterone Replacement Therapy by Regions

      • 4.1 Testosterone Replacement Therapy by Regions
        • 4.1.1 Global Testosterone Replacement Therapy Consumption by Regions
        • 4.1.2 Global Testosterone Replacement Therapy Value by Regions
      • 4.2 Americas Testosterone Replacement Therapy Consumption Growth
      • 4.3 APAC Testosterone Replacement Therapy Consumption Growth
      • 4.4 Europe Testosterone Replacement Therapy Consumption Growth
      • 4.5 Middle East & Africa Testosterone Replacement Therapy Consumption Growth

      5 Americas

      • 5.1 Americas Testosterone Replacement Therapy Consumption by Countries
        • 5.1.1 Americas Testosterone Replacement Therapy Consumption by Countries (2014-2019)
        • 5.1.2 Americas Testosterone Replacement Therapy Value by Countries (2014-2019)
      • 5.2 Americas Testosterone Replacement Therapy Consumption by Type
      • 5.3 Americas Testosterone Replacement Therapy Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Testosterone Replacement Therapy Consumption by Countries
        • 6.1.1 APAC Testosterone Replacement Therapy Consumption by Countries (2014-2019)
        • 6.1.2 APAC Testosterone Replacement Therapy Value by Countries (2014-2019)
      • 6.2 APAC Testosterone Replacement Therapy Consumption by Type
      • 6.3 APAC Testosterone Replacement Therapy Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Testosterone Replacement Therapy by Countries
        • 7.1.1 Europe Testosterone Replacement Therapy Consumption by Countries (2014-2019)
        • 7.1.2 Europe Testosterone Replacement Therapy Value by Countries (2014-2019)
      • 7.2 Europe Testosterone Replacement Therapy Consumption by Type
      • 7.3 Europe Testosterone Replacement Therapy Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Testosterone Replacement Therapy by Countries
        • 8.1.1 Middle East & Africa Testosterone Replacement Therapy Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Testosterone Replacement Therapy Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Testosterone Replacement Therapy Consumption by Type
      • 8.3 Middle East & Africa Testosterone Replacement Therapy Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Testosterone Replacement Therapy Distributors
      • 10.3 Testosterone Replacement Therapy Customer

      11 Global Testosterone Replacement Therapy Market Forecast

      • 11.1 Global Testosterone Replacement Therapy Consumption Forecast (2019-2024)
      • 11.2 Global Testosterone Replacement Therapy Forecast by Regions
        • 11.2.1 Global Testosterone Replacement Therapy Forecast by Regions (2019-2024)
        • 11.2.2 Global Testosterone Replacement Therapy Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Testosterone Replacement Therapy Forecast by Type
      • 11.8 Global Testosterone Replacement Therapy Forecast by Application

      12 Key Players Analysis

      • 12.1 AbbVie
        • 12.1.1 Company Details
        • 12.1.2 Testosterone Replacement Therapy Product Offered
        • 12.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 AbbVie News
      • 12.2 Endo International
        • 12.2.1 Company Details
        • 12.2.2 Testosterone Replacement Therapy Product Offered
        • 12.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Endo International News
      • 12.3 Eli lilly
        • 12.3.1 Company Details
        • 12.3.2 Testosterone Replacement Therapy Product Offered
        • 12.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Eli lilly News
      • 12.4 Pfizer
        • 12.4.1 Company Details
        • 12.4.2 Testosterone Replacement Therapy Product Offered
        • 12.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Pfizer News
      • 12.5 Actavis (Allergan)
        • 12.5.1 Company Details
        • 12.5.2 Testosterone Replacement Therapy Product Offered
        • 12.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Actavis (Allergan) News
      • 12.6 Bayer
        • 12.6.1 Company Details
        • 12.6.2 Testosterone Replacement Therapy Product Offered
        • 12.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Bayer News
      • 12.7 Novartis
        • 12.7.1 Company Details
        • 12.7.2 Testosterone Replacement Therapy Product Offered
        • 12.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Novartis News
      • 12.8 Teva
        • 12.8.1 Company Details
        • 12.8.2 Testosterone Replacement Therapy Product Offered
        • 12.8.3 Teva Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Teva News
      • 12.9 Mylan
        • 12.9.1 Company Details
        • 12.9.2 Testosterone Replacement Therapy Product Offered
        • 12.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Mylan News
      • 12.10 Upsher-Smith
        • 12.10.1 Company Details
        • 12.10.2 Testosterone Replacement Therapy Product Offered
        • 12.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Upsher-Smith News
      • 12.11 Ferring Pharmaceuticals
      • 12.12 Kyowa Kirin
      • 12.13 Acerus Pharmaceuticals

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Testosterone Replacement Therapy . Industry analysis & Market Report on Testosterone Replacement Therapy is a syndicated market report, published as Global Testosterone Replacement Therapy Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Testosterone Replacement Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,917.02
      4,375.53
      5,834.04
      3,400.14
      5,100.21
      6,800.28
      560,821.80
      841,232.70
      1,121,643.60
      305,390.40
      458,085.60
      610,780.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report